Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent/Metastatic Endometrial Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00006903
What this trial is testing

Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer

Who this might be right for
Recurrent Uterine Corpus CarcinomaStage III Uterine Corpus Cancer AJCC v7Stage IV Uterine Corpus Cancer AJCC v7
Gynecologic Oncology Group 67
Testing effectiveness (Phase 2)Ended earlyNCT03485729
What this trial is testing

ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer

Who this might be right for
Endometrial Cancer Recurrent
Jazz Pharmaceuticals 27
Large-scale testing (Phase 3)Looking for participantsNCT03651206
What this trial is testing

Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib

Who this might be right for
Ovarian CarcinosarcomaEndometrial Carcinosarcoma
ARCAGY/ GINECO GROUP 138
Testing effectiveness (Phase 2)Active Not RecruitingNCT05538897
What this trial is testing

Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers

Who this might be right for
FIGO Grade 1 Endometrial Endometrioid AdenocarcinomaFIGO Grade 2 Endometrial Endometrioid AdenocarcinomaMetastatic Endometrial Endometrioid Adenocarcinoma+1 more
National Cancer Institute (NCI)
Early research (Phase 1)Active Not RecruitingNCT05691504
What this trial is testing

Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers

Who this might be right for
Advanced Endometrial CarcinomaMetastatic Endometrial CarcinomaMetastatic Fallopian Tube Carcinoma+8 more
National Cancer Institute (NCI) 42
Large-scale testing (Phase 3)Study completedNCT01767155
What this trial is testing

Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer

Who this might be right for
Endometrial Cancer
AEterna Zentaris 511
Not applicableEnded earlyNCT05891197
What this trial is testing

A Biomarker Screening Protocol for Participants With Solid Tumors

Who this might be right for
Triple Negative Breast CancerNon-small Cell Lung CancerNon Small Cell Lung Cancer+19 more
Lyell Immunopharma, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT00870337
What this trial is testing

Everolimus in Treating Patients With Relapsed or Metastatic Endometrial Cancer

Who this might be right for
Endometrial Cancer
ARCAGY/ GINECO GROUP 44
Testing effectiveness (Phase 2)Study completedNCT00004251
What this trial is testing

Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Endometrial Cancer
NCIC Clinical Trials Group 33
Testing effectiveness (Phase 2)Ended earlyNCT05798611
What this trial is testing

Study of ART0380 in Patients With Biologically Selected Solid Tumors

Who this might be right for
Advanced Solid TumorRecurrent Endometrial CancerMetastatic Cancer
Artios Pharma Ltd 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06751277
What this trial is testing

QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Recurrent or Metastatic Endometrial Cancer
xiang yang 26
Testing effectiveness (Phase 2)Looking for participantsNCT07054567
What this trial is testing

BL-B01D1 + Pembrolizumab ± Bevacizumab in Patients With Recurrent or Metastatic Cervical Cancer and Endometrial Cancer

Who this might be right for
Cervical CancerEndometrial Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 96
Testing effectiveness (Phase 2)UnknownNCT03951415
What this trial is testing

Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer

Who this might be right for
Endometrial NeoplasmsUterine NeoplasmsEndometrium Cancer
Leiden University Medical Center 55
Large-scale testing (Phase 3)UnknownNCT02584478
What this trial is testing

Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)

Who this might be right for
Endometrial CarcinomaOvarian CarcinomaFallopian Tube Carcinoma+2 more
Advenchen Laboratories, LLC 294
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06620029
What this trial is testing

BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial Cancer

Who this might be right for
Ovarian NeoplasmsEndometrial Cancer, Endometrial Neoplasm
BioMimetix JV, LLC 27
Testing effectiveness (Phase 2)Ended earlyNCT01184053
What this trial is testing

Trisenox® in Women With Metastatic Endometrial Cancer

Who this might be right for
Endometrial Carcinoma
UNC Lineberger Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00052312
What this trial is testing

Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer

Who this might be right for
Endometrial Cancer
European Organisation for Research and Treatment of Cancer - EORTC 141
Testing effectiveness (Phase 2)Study completedNCT02730429
What this trial is testing

Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer

Who this might be right for
Endometrial Cancer
Nordic Society of Gynaecological Oncology - Clinical Trials Unit 78
Testing effectiveness (Phase 2)WithdrawnNCT01550380
What this trial is testing

BKM120 in Advanced, Metastatic, or Recurrent Endometrial Cancers

Who this might be right for
Endometrial Cancer
University of Utah
Early research (Phase 1)Ended earlyNCT06625515
What this trial is testing

First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers

Who this might be right for
Advanced Solid TumorsBreast Cancer RecurrentColorectal Cancer Metastatic+3 more
Accent Therapeutics 17
Next Page
96